WASHINGTON, Oct. 22 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved Gilead Sciences' antiviral drug Veklury (remdesivir) as a treatment for COVID-19.
Previously authorized by the FDA for emergency use to treat COVID-19, Veklury is now the first and only approved COVID-19 treatment in the United States, said Gilead in a statement.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!